[Immunomodulation after organ grafting by novel immunosuppressive drug and gene transfection].
Suzuki
S
S
Li
X K
XK
Okuyama
T
T
Tamura
A
A
Funeshima
N
N
Enosawa
S
S
Ohba
M
M
Amemiya
H
H
D000818:Animals; D000954:Antigens, Surface / Q000235:genetics; D017209:Apoptosis; D053222:Fas Ligand Protein; D000068876:Fingolimod Hydrochloride; D006084:Graft Rejection / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008024:Ligands; D008562:Membrane Glycoproteins / Q000235:genetics; D016377:Organ Transplantation; D011409:Propylene Glycols / Q000627:therapeutic use; D013110:Sphingosine / Q000031:analogs & derivatives; D014162:Transfection; D019014:fas Receptor / Q000235:genetics
D000954:Antigens, Surface; D053222:Fas Ligand Protein; D007166:Immunosuppressive Agents; D008024:Ligands; D008562:Membrane Glycoproteins; D011409:Propylene Glycols; D019014:fas Receptor; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine